Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

RNA vaccines

Alt-RNAtive vaccines elicit anti-malarial TRM cells

Malaria is a vector-borne disease caused by Plasmodium parasites. In an exciting new study, Ganley et al. harness the power of mRNA vaccines to summon tissue-resident memory T cells to battle the parasite as it replicates in the liver.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1: Incorporation of modified α-GalCer in LNPs promotes the formation of anti-malarial liver TRM cells and parasite clearance.

References

  1. CDC. About Malaria https://www.cdc.gov/malaria/about/disease.html (accessed 3 March 2022).

  2. Ganley, M. et al. Nat. Immunol. https://doi.org/10.1038/s41590-023-01562-6 (2023).

    Article  PubMed  Google Scholar 

  3. Hassert, M., Arumugam, S. & Harty, J. T. Immunol. Rev. https://doi.org/10.1111/imr.13202 (2023).

    Article  PubMed  Google Scholar 

  4. Coulibaly, D. et al. EClinicalMedicine 52, 101579 (2022).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Fernandez-Ruiz, D. et al. Immunity 45, 889–902 (2016).

    Article  CAS  PubMed  Google Scholar 

  6. Lefebvre, M. N. et al. Cell Rep. 37, 109956 (2021).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Schenkel, J. M. & Masopust, D. Immunity 41, 886–897 (2014).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Santacatterina, M., Sanders, J. W. & Weintraub, W. S. N. Engl. J. Med. 385, 1817–1818 (2021).

    Article  CAS  PubMed  Google Scholar 

  9. Holz, L. E. et al. Sci. Immunol. 5, eaaz8035 (2020).

    Article  CAS  PubMed  Google Scholar 

  10. Liao, C. M., Zimmer, M. I. & Wang, C. R. Inflamm. Bowel Dis. 19, 1330–1338 (2013).

    Article  PubMed  Google Scholar 

  11. Yoshimoto, T. Front. Immunol. 9, 716 (2018).

    Article  PubMed  PubMed Central  Google Scholar 

  12. Hildner, K. et al. Science 322, 1097–1100 (2008).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Kurup, S. P. et al. Cell Host Microbe 25, 565–577.e6 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Ocaña-Morgner, C., Mota, M. M. & Rodriguez, A. J. Exp. Med. 197, 143–151 (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  15. Pardi, N. et al. J. Control Release 217, 345–551 (2015).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to John T. Harty.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hassert, M., Harty, J.T. Alt-RNAtive vaccines elicit anti-malarial TRM cells. Nat Immunol 24, 1397–1398 (2023). https://doi.org/10.1038/s41590-023-01594-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41590-023-01594-y

Search

Quick links

Nature Briefing Microbiology

Sign up for the Nature Briefing: Microbiology newsletter — what matters in microbiology research, free to your inbox weekly.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing: Microbiology